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Abstract
Background: Pregnancy is a state of increased requirement of macro- and micronutrients, and malnourishment or
inadequate dietary intake before and during pregnancy, can lead to adverse perinatal outcomes including
stillbirths. Many nutritional interventions have been proposed during pregnancy according to the nutritional status
of the mother and baseline risk factors for different gestational disorders. In this paper, we have reviewed three
nutritional interventions including peri-conceptional folic acid supplementation, balanced protein energy
supplementation and multiple micronutrients supplementation during pregnancy. This paper is a part of a series to
estimate the effect of interventions on stillbirths for input to Live Saved Tool (LiST) model.
Methods: We systematically reviewed all published literature to identify studies evaluating effectiveness of peri-
conceptional folic acid supplementation in reducing neural tube defects (NTD), related stillbirths and balanced
protein energy and multiple micronutrients supplementation during pregnancy in reducing all-cause stillbirths. The
primary outcome was stillbirths. Meta-analyses were generated where data were available from more than one
study. Recommendations were made for the Lives Saved Tool (LiST) model based on rules developed by the Child
Health Epidemiology Reference Group (CHERG).
Results: There were 18 studies that addressed peri-conceptional folic acid supplementation for prevention of neural
tube defects (NTDs). Out of these, 7 studies addressed folic acid supplementation while 11 studies evaluated effect of
folic acid fortification. Pooled results from 11 fortification studies showed that it reduces primary incidence of NTDs by 41
% [Relative risk (RR) 0.59; 95 % confidence interval (CI) 0.52-0.68]. This estimate has been recommended for inclusion in
the LiST as proxy for reduction in stillbirths. Pooled results from three studies considered to be of low quality and
suggest that balanced protein energy supplementation during pregnancy could lead to a reduction of 45% in stillbirths
[RR 0.55, 95 % CI 0.31-0.97]. While promising, the intervention needs more effectiveness studies before inclusion in any
programs. Pooled results from 13 studies evaluating role of multiple micronutrients supplementation during pregnancy
showed no significant effect in reducing stillbirths [RR = 0.98; 95% CI: 0.88 – 1.10] or perinatal mortality [RR = 1.07; 95% CI:
0.92 – 1.25; random model]. No recommendations have been made for this intervention for inclusion in the LiST model.
Conclusions: Peri-conceptional folic acid supplementation reduces stillbirths due to NTDs by approximately 41%, a
point estimate recommended for inclusion in LiST.
Background
The nutritional status of a woman before and during
pregnancy is important for a healthy pregnancy outcome
[1]. Pregnancy is a state of increased requirement of
macro and micronutrients, and malnourishment or
inadequate dietary intake before and during pregnancy,
can lead to adverse perinatal outcomes [2,3].
Stillbirth is an important adverse outcome of preg-
nancy. Global estimates suggest that at least 3.2 million
stillbirths occur annually [4], with 98% of these occurring
in the developing world [5]. The risk factors for stillbirths
in the low-/middle-income countries are myriad, and a
systematic review by Di Mario et al. concluded that poor* Correspondence: zulfiqar.bhutta@aku.edu
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maternal nutritional status is one of the five factors sig-
nificantly associated with stillbirths [6].
Many nutritional interventions have been proposed for
pregnant mothers. These include multiple micronutri-
ents (MMN), iron/folate, balanced protein energy, cal-
cium, zinc and folic acid supplementation [7-11]. Some
of these interventions are recommended universally for
all women while some are proposed in the context of
the nutritional status of mothers which may vary in dif-
ferent populations [3,12]. For example calcium is given
during pregnancy for prevention of gestational hyperten-
sive disorders but is effective only in populations with
low baseline calcium intake [8,13]. Similarly iodine sup-
plementation is effective in populations with iodine defi-
ciency only.
In this review, our intention is to assess the evidence of
the impact of three different nutritional interventions
during pregnancy on stillbirths. We have reviewed the
effect of peri-conceptional folic acid supplementation,
balanced protein energy supplementation and multiple
micronutrient supplements during pregnancy. This selec-
tion was based on an existing review of nutritional inter-
ventions for the prevention of stillbirths [14]. and only
those interventions have been selected that have a proven
benefit for reducing stillbirths or have a strong biological
plausibility and now we review them in more depth.
Calcium supplementation during pregnancy has been
reviewed in another paper for this supplement [15]. This
paper is a part of a series of papers to estimate effective-
ness of an intervention for input into the Lives Saved
Tool (LiST) [16]. The process of generating recommen-
dations for an intervention involve qualitative evaluation
of available evidence according to Grading of Recommen-
dations, Assessment, Development and Evaluation
(GRADE) criteria [17] and quantitative evaluation accord-
ing to Child Health Epidemiology Reference Group
(CHERG) rules [16]. For more details of the review meth-
ods, the adapted GRADE approach or the LiST model,
see the CHERG method’s paper [16]. The following are
the objectives of this review.
1. To estimate the effectiveness of peri-conceptional
folic acid supplementation in reducing neural tube
defects (NTDs) related stillbirths.
2. To estimate the effectiveness of balanced protein
energy supplementation during pregnancy in reducing
all-cause stillbirths.
3. To estimate the effectiveness of multiple micronu-
trient supplementation during pregnancy in reducing
all-cause stillbirths.
Methods
Search
We systematically reviewed all published literature to
identify studies addressing peri-conceptional folic acid
supplementation, balanced protein energy and multiple
micronutrient supplements during pregnancy. The
search strategies used for the above mentioned nutri-
tional interventions on PubMed are given as appendices
1, 2 and 3 respectively in Additional File 1. The last
date of the search was 3rd March 2010. Initial search
identified titles and abstracts relevant to the interven-
tions of interest. Full texts were then retrieved for
selected studies for final inclusion and for data abstrac-
tion. We also reviewed the reference lists of identified
articles, existing reviews and meta-analyses to identify
studies that were not picked up in the main search.
Authors were contacted for any additional data, if
required.
Inclusion/exclusion criteria
All randomized and quasi-randomized controlled trials
assessing impact of peri-conceptional folic acid, balanced
protein energy and multiple micronutrients supplements
during pregnancy outcomes, were eligible for inclusion.
Studies were included irrespective of language or publica-
tion status. We also reviewed observational studies for
peri-conceptional folic acid supplementation as very few
trials were conducted after huge protective effects of
supplementation as shown in MRC trial [18]. Balanced
protein energy supplementation was defined as nutri-
tional supplementation during pregnancy in which pro-
teins provided less than 25% of the total energy content
[9]. Those studies were excluded in which the main inter-
vention was simply dietary advice to pregnant women to
increase protein intake, high protein supplementation
(i.e. supplementation in which protein provided at least
25% or more of total energy content), isocaloric protein
supplementation (where protein replaces an equal quan-
tity of non-protein energy content), or low energy diets
for pregnant women. Multiple micronutrients were
defined as supplementation with at least five micronutri-
ents and were compared with iron folic acid supplemen-
tation alone [7].
Data abstraction and validity assessment
Every study that met the eligibility criteria was reviewed
in detail and its characteristics abstracted into a standar-
dized form [16]. The main variables extracted were
country of the study, quality of allocation concealment,
blinding status, characteristics of participants, sample
size, description of intervention that included para-
meters like dose, frequency and duration of the supple-
ments, and the follow-up period. All the studies were
then graded according to the CHERG adaptation of the
GRADE technique [16,17]. Each study was allocated a
quality score of ‘high’ ‘moderate’ ‘low’ or ‘very low’. This
assessment was based on the methodological quality of
the study and consistency of results compared to that of
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other selected studies [16]. Any study getting a final
score of ‘very low’ was excluded from the review [16,17].
The detailed data extraction with the limitation of stu-
dies is shown in Additional File 2.
Quantitative data synthesis
We generated meta-analyses where data were available
from more than one study. Dichotomous data were com-
bined to get a pooled relative risk. In case where data
from all the studies were not available in dichotomous
form and risk ratios were available, meta-analysis was
performed by generic inverse variance (GIV) method.
This method is advantageous in these scenarios as it
requires standard error (SE) and natural ‘log’ of effect
size and data can be pooled without numerators and
denominators [19]. For cluster randomized trials, we
used the stated cluster adjusted relative risk and 95%
confidence interval, irrespective of the method used. In
case cluster adjustment was not done in the study, it was
done by either adjusting the original sample size or inflat-
ing the SE times square of design effect [19]. Heterogene-
ity of the meta-analysis was assessed by visual inspection
i.e. the overlap of the confidence intervals among the stu-
dies, and by the Chi square (P-value) of heterogeneity in
the meta-analyses and I2 value. A low P value (less than
0.10) or a large chi-squared statistic relative to its degree
of freedom (I2 >50 %) was considered as providing evi-
dence of significant heterogeneity. In situations of sub-
stantial or high heterogeneity being present, causes were
explored by sensitivity analysis. Fixed models were used
for primary analysis and random models were used in
case of significant heterogeneity in the pooled estimate.
Results are presented as Mantel-Haenszel risk ratios (RR)
and corresponding 95% confidence intervals (CI). All
meta-analyses were conducted using software Review
Manager Version 5 [20].
For recommendations to the LiST model, we summar-
ized the evidence for each outcome including qualitative
assessment of ‘overall’ evidence according to GRADE
criteria and quantitative measures according to standard
guidelines of the Child Health Epidemiological Review
Group (CHERG) [16]. The qualitative evaluation of the
overall (pooled) evidence was based on the volume and
consistency of the evidence across studies, the size of
pooled relative risk and the strength of the statistical
evidence for an association between the intervention
and the health outcome as reflected in the p-value [16].
Results
Peri-conceptional folic acid supplementation
The literature search identified 754 titles (Figure 1).
After initial screenings of titles or abstracts and after
duplicates were removed, we reviewed 26 studies. Eight
studies were further excluded after review of full texts.
Finally, data for eighteen studies were abstracted. One
Cochrane [10] and one LiST review [21] were also avail-
able on the topic.
Out of eighteen selected studies, seven studies evalu-
ated the effect of peri-conceptional folic acid supple-
mentation [18,22-27] and eleven studies assessed
fortification of food with folic acid [28-38]. All the forti-
fication studies were before and after studies. Of the
seven supplementation studies, there were four rando-
mized controlled trials [18,23,24,26] and three cohort
studies [22,25,27]. Four of the supplementation studies
addressed primary prevention of neural tube defects
[22,23,25,27] and three that of secondary preventions
[18,24,26]. Meta-analysis of four studies (1 RCT and 3
cohort studies) for primary prevention of NTDs showed
a reduction of 62 % in the incidence of NTDs [relative
risk (RR) 0.38; 95 % confidence interval (CI) 0.29-0.51, I
squared (I2) =27.9 %, fixed model] (data not shown).
The overall quality grade for this consistent pooled esti-
mate with 1 RCT [23] and 3 cohort studies [22,25,27]
was that of ‘moderate’ level. Disaggregated data for still-
birth due to NTDs were not available from any of these
studies. Pooled results of three RCTs for prevention of
recurrent NTDs showed a reduction of 70 % in recur-
rence of NTDs [RR 0.30; 95 % CI 0.14-0.65, I2 =0 %,
fixed model] (data not shown). As the evidence came
from RCTs and the pooled estimate was consistent, the
overall quality grade for this estimate was that of ‘high’
level. In these studies, disaggregated data for stillbirths
due to NTDs were available from one study [24] with
one stillbirth in the control group and no stillbirth in
the intervention group, giving a relative risk of 0.17 (95
% CI 0.01-0.46).
There were eleven before and after studies that addressed
primary prevention of NTDs using folic acid fortification.
Pooled results from these studies showed a reduction of 41
% in primary occurrence of NTDs [RR 0.59; 95 % CI 0.52-
0.68, I2 =88 %, random model] (Figure 2). As there was a
significant heterogeneity in the pooled estimate, random
models were used. Ten of the included studies showed a
clear benefit. The reason for significant heterogeneity was
the difference in magnitude of ‘effect size’ of the included
studies which ranged from a reduction of 26 % [33] to 78
% [38]. Although this evidence came from ‘low’ quality
before and after studies, the overall quality grade for this
estimate was that of ‘moderate’ level due to prominent pro-
tective effect in the same direction in most of the included
studies. The disaggregated data for stillbirths due to NTDs
was available from one study [31] with 5 stillbirths in inter-
vention group and 29 in the control group giving a relative
risk of 0.41 (95 % CI 0.16-1.07). This study from Canada
found that before fortification (1992-1997), there were 29
stillbirths related to neural tube defects, out of a total of
531268 births, a cause-specific stillbirth rate of 5.5 per
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100000 births. The corresponding figure after fortification
(1998-2000) was 5 stillbirths out of 221 253, a rate of 2.3
per 100000.
Table 1 shows the summary of findings and qualitative
assessment of evidence on folic acid supplementation/
fortification in prevention of NTDs and related stillbirths.
Keeping in mind the inadequacy of direct data on NTDs
related stillbirth, we recommend an approximate
reduction of 41% in NTD related stillbirths with an over-
all quality grade of “moderate”.
Balanced protein energy supplementation during
pregnancy
We identified 4160 titles from searches conducted in all
databases (Figure 3). After screening the titles and
abstracts, 22 studies were identified that addressed
Searchresults
Pubmed:642
WHOregionaldatabases:106
Cochrane:1
LiSTreviewonthetopic:1
Additionalrecordsidentified
throughhandsearch
(n=4)

Recordsscreened
(n=754)
Records
excluded
(n=728)
FullͲtextarticlesassessed
foreligibility
(n=26)
FullͲtextarticles
excluded
(n=8)
Studiesincludedin
quantitativesynthesis
(metaͲanalysis)
(n=18)
Primaryprevention
ofSpinabifida=10
Primaryprevention
ofAnencephaly=10
Primaryprevention
ofAllNTDs=11
Folicacidfortificationstudies=11
(Allbeforeandafter)
Folicacidsupplementation
studies=7
(4RCT3cohort)
Primaryprevention=4
SecondaryPrevention=3
Figure 1 Flow diagram for identification of studies evaluating peri-conceptional Folic acid supplementation for prevention of stillbirths due to
neural tube defects.
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protein/energy supplementation during pregnancy. Eight
of these studies were excluded because the intervention
in these studies was either dietary advice about increase
in protein/energy content, supplementation with isoca-
loric or high protein food [39-46]. Fourteen studies
addressed balanced protein/energy supplementation
during pregnancy [47-60]. Two of these studies were
excluded because both the groups received food supple-
mentation (high versus low energy) [53,54]. Another
study was excluded because of ‘very low’ quality [60].
Eight studies were excluded because data for outcome
of interest was not available [47-49,51,52,56,58,59].
Finally three studies were included in the review
[50,55,57]. A Cochrane review was also available on the
topic [9]. Two of the included studies were from devel-
oping countries [50,55] and one from a developed coun-
try [57]. The participants in all three studies were
malnourished (as defined by authors). Pooled results
from these three studies included a total of 2186 preg-
nancies and 49 stillbirths, showed that balanced protein
energy supplementation during pregnancy leads to a
significant reduction of 45% in all-cause stillbirths [RR
0.55, 95 % CI 0.31-0.97] (Figure 4). The overall grade
quality of pooled data was that of ‘Low’ level (Table 2).
Risk Ratio
Study or Subgrouplog[Risk Ratio] IV, Random, 95% CI
Risk Ratio
WeightSE IV, Random, 95% CI
Bower 2009
Calvo 2008
Chen 2008
De Wals 2003
De Wals 2007
Liu 2004
Lopez 2005
Persad 2002
Ray 2002
Sayed 2008
Williams 2002
Total (95% CI)
Heterogeneity: Tau² = 0.04; Chi² = 81.20, df = 10 (P < 0.00001); I² = 88%
Test for overall effect: Z = 7.61 (P < 0.00001)
-0.30110.0707 0.74 [0.64, 0.85]
-0.59780.0692
-0.16250.0829
-0.38560.0634
-0.61610.0537
-1.514
-0.73390.1138
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-0.65390.1293
-0.371
-0.30110.0333
0.2368
0.1789
10.6%
0.55 [0.48, 0.63]10.6%
0.85 [0.72, 1.00]10.2%
0.68 [0.60, 0.77]10.8%
0.54 [0.49, 0.60]11.1%
0.22 [0.14, 0.35]5.0%
0.48 [0.38, 0.60]9.0%
0.46 [0.32, 0.67]6.2%
0.52 [0.40, 0.67]8.4%
0.69 [0.49, 0.98]6.6%
0.74 [0.69, 0.79]11.6%
0.59 [0.52, 0.68]100.0%
10.2 0.5 2 5
Favors experimentalFavors control
Figure 2 Effect of folic acid fortification on prevention of neural tube defects. Meta-analysis based on results of 11 before and after studies.
Table 1 Quality assessment of studies of peri-conceptional folic acid supplementation (by fortification) to prevent
stillbirths from neural tube defects
Quality Assessment Directness Summary of findings
No. of
studies
(Ref)
Design Limitations Consistency Generalizability
to Population
of Interest
Generalizability
to intervention
of Interest
Events in
intervention
group
Events
in
control
group
Relative Risk
(95 % CI)
NTDs related stillbirths: Low outcome specific quality
1 Before
and
after
study
Only one study. Total event <
50 so cannot be considered
for inclusion in the LiST
Only one
study
Study from
Canada
Folic acid
fortification study
5 29 0.41
(0.16-1.07)a
NTD incidence: Moderate outcome specific quality
11 Before
and
after
Low quality population based
studies
Significant
heterogeneity
(I2 = 88%)
All studies from
high-middle
income countries
Folic acid
fortification
studies
0.59
(0.52-0.68)b
a: directly calculated from study data, b: pooled estimate calculated by generic inverse variance.
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Multiple micronutrient supplements during pregnancy
A total of 4478 titles were identified from our search
strategy (Figure 5). After screening the titles and
abstracts, 13 studies were selected for inclusion in this
paper [61-73]. Six of these 13 studies were cluster ran-
domized trials [67-69,71,73,74]. Supplementation with
multiple micronutrients failed to show a significant
reduction in stillbirths when compared to iron folate
supplementation (RR = 0.98; 95% CI: 0.88 – 1.10)
(Figure 6). The impact on perinatal mortality was similar
[RR 1.07, 95 % CI 0.92 –1.25] (Data not shown). As
there was no significant effect of multiple micronutrient
supplementation in reducing stillbirth or perinatal mor-
tality, no recommendations have been made for LiST
for this intervention (Table 3).
Discussion
Evidence from a Cochrane review by Lumley et al. 2001
showed that peri-conceptional folic acid supplementation
has a significant protective effect on occurrence of neural
tube defects [RR 0.28, 95% CI 0.13–0.58], particularly in
women who had a previous pregnancy affected by it
(recurrent neural tube defects) [RR 0.31, 95% CI 0.14–
0.66] [10]. A review by Blencowe et al. for Lives Saved
Totalsearches
Pubmed:4098
Cochrane:1
WHOregionaldatabases=56
Additionalrecordsidentified
throughothersources
(n=5)
Records
excluded
(n=4138)
Recordsscreened
(n=4160)
FullͲtextarticlesexcluded
(n=19)
FullͲtextarticlesassessed
foreligibility
(n=22)
Studiesincludedin
quantitativesynthesis
(metaͲanalysis)
(n=3)
Figure 3 Flow diagram for identification of studies evaluating balanced protein energy supplementation during pregnancy for prevention of
stillbirths.
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Tool has shown that folic acid supplementation can
reduce the primary incidence of NTDs by 62 % [RR 0.38;
95 % CI 0.29-0.51] and recurrence of NTDs by 70 %. [RR
0.30; 0.14-0.65] [21]. They also pooled data for fortifica-
tion studies and showed a reduction of 46 % in primary
incidence of NTDs. Our pooled estimates for primary
prevention of neural tube defects by folic acid supple-
mentation/fortification are similar to these reviews. The
pooled estimate for folic acid fortification showed a
reduction of 41 % (95 % CI 32 % to 48 %) in the occur-
rence NTDs. The small difference in effect size compared
to previous LiST review was because we added three
more studies to the previous met-analysis [28,30,32].
There was no convincing evidence from the current
published literature in favor or against of peri-concep-
tional folic acid supplementation/fortification for pre-
vention of stillbirths due to NTDs. Although it can be
argued that a reduction in NTDs should be associated
with a reduction in stillbirths, most of the studies did
not report disaggregated data on proportion of stillbirths
due to NTDs. Only one supplementation study [24] and
one fortification study [31] reported direct data on NTD
related stillbirths. We know from the previous literature
that a major proportion of anencephalic babies and
those with spina bifida cystica result in stillbirths
[75-77]. Given the strong biological plausibility in favor
of the intervention based on results of supplementation
and fortification studies, we assumed that reduction in
NTD incidence would be equal to reduction in NTDs
related stillbirths with equal rates of incidence and fatal-
ities of Anencephaly and Spina Bifida. It is important to
mention that this estimate is applied to NTD related
stillbirths only and the absolute effect of folic acid forti-
fication for all-cause stillbirths will depend on the cover-
age of intervention and baseline incidence of NTDs in
any given population.
We based our recommendations on folic acid fortifica-
tion studies rather that of synthetic supplementation.
This is based on the observation that widespread adop-
tion of policies of folic acid supplementation in many
developed countries have yielded disappointing results
at a public health level [81]. The main contributing fac-
tors to this could be a relatively high proportion of
unplanned pregnancies [82] and lack of easy access to a
functioning health system and effective local social mar-
keting interventions [23]. A policy of folic acid supple-
mentation would be even more difficult to implement in
low-income countries with high levels of poverty, poor
health-care infrastructure and more number of
unplanned pregnancies compared to developed
Study or Subgroup
Ceesay 1997
Mora 1978
Rush 1980
Total (95% CI)
Total events
Heterogeneity: Chi² = 2.49, df = 2 (P = 0.29); I² = 20%
Test for overall effect: Z = 2.08 (P = 0.04)
Events
7
2
9
18
Total
652
221
270
1143
Events
13
8
10
31
Total
545
222
276
1043
Weight
44.2%
24.9%
30.9%
100.0%
M-H, Fixed, 95% CI
0.45 [0.18, 1.12]
0.25 [0.05, 1.17]
0.92 [0.38, 2.23]
0.55 [0.31, 0.97]
Experimental Control Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 4 Effect of balanced protein energy supplementation during pregnancy on stillbirths.
Table 2 Quality assessment of studies of balanced protein energy supplementation during pregnancy to prevent
stillbirths
Quality Assessment Directness Summary of findings
No. of
studies
(Ref)
Design Limitations Consistency Generalizability to
Population of
Interest
Generalizability
to intervention
of Interest
Events in
intervention
group
Events
in
control
group
Relative Risk
(95 % CI)
Stillbirth: Low outcome specific quality
3 RCT
and
quasi
RCT
Methods of sequence
generation and
allocation
concealment were
not adequate in two
of the included
studies
Heterogeneity
in the pooled
data was not
significant
(I2=20%)
One of the study from
developed country
(USA); however, the
participants in this
study were from lower
socioeconomic status
Different studies
used different
composition of
formula for
delivery of
balance protein
energy.
18 31 0.55 (0.31-0.97)
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countries [23,81,83,84]. Folic acid fortification seems a
more suitable option for developing countries but it
requires careful considerations including level of folic
acid fortification and selection of suitable food vehicle.
For example in certain population use of rice may be
more common than flour or maize.
It is important to note that the effect of folic acid on
incidence of NTDs and related stillbirths will be different
in different countries. The amount of protective effect
will depend on baseline NTDs incidence rate, folate defi-
ciency in child bearing women, genetic susceptibility and
existing system for screening and termination of affected
Totalsearches
Pubmed:4385
Cochrane:1
WHOregionaldatabases=85
Records
excluded
(n=4435)
Recordsscreened
(n=4478)
Additionalrecordsidentified
throughothersources
(n=7)
FullͲtextarticlesexcluded
(n=30)
FullͲtextarticlesassessed
foreligibility
(n=43)
Studiesincludedin
quantitativesynthesis
(metaͲanalysis)
(n=13)
Stillbirth=13 Perinatalmortality=11
Figure 5 Flow diagram for identification of studies evaluating multiple micronutrient supplementations during pregnancy for prevention of
stillbirths.
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pregnancies [75,78]. For example in one part of China,
incidence of NTDs is much higher than other regions in
the country and folic acid supplementation was more
effective in reducing NTDs in this area compared to
others [25]. The estimate in our meta-analysis of folic
acid-fortification effect is based primarily on white popu-
lations and the effect may differ in different races. A
before and after study from USA reported not only lower
background NTD rates amongst black Americans com-
pared to Hispanic or white groups, but also a reduced
effect of folic acid fortification in the black American
group [38]. This indicates that a policy of folic acid forti-
fication may yield different results in different popula-
tions across the developing and developed countries.
The beneficial effects of folic acid may extend beyond
NTDs and related stillbirths. A recent review by Blen-
cowe et al. for Live Saved Tool has shown that folic acid
fortification can reduce congenital anomalies related
neonatal mortality by 13 % [21]. A study from Canada
has shown that folic acid fortification reduced incidence
of severe congenital heart diseases [79]. Another study
has reported that folic acid supplementation can reduce
spontaneous preterm delivery [80].
Balance protein energy supplementation has been
shown to have a significant reduction on incidence of
intrauterine growth restriction [2,9]. The current analy-
sis suggests that it could also reduce occurrence of still-
births [RR 0.55, 95 % CI 0.31-0.97]. There was no
Study or Subgroup
Ramakrishnan
Christian
Friis
Osrin
Kaestel
Fawzi
Zagre
Tofail
Roberfroid
Sunawang
SUMMIT
Zeng
Bhutta
Total (95% CI)
Heterogeneity: Chi² = 19.48, df = 12 (P = 0.08); I² = 38%
Test for overall effect: Z = 0.28 (P = 0.78)
log[Risk Ratio]
0.2151
0.3853
-0.5978
-0.1863
-0.7133
-0.1392
0.1655
0
0.802001
-0.1053
-0.1053
0.3001
0.1398
SE
0.6601
0.2306
0.6299
0.3475
0.304
0.1182
0.1982
0.2867
0.4247
0.4818
0.09302
0.1902
0.1981
Weight
0.7%
5.7%
0.8%
2.5%
3.3%
21.7%
7.7%
3.7%
1.7%
1.3%
35.0%
8.4%
7.7%
100.0%
IV, Fixed, 95% CI
1.24 [0.34, 4.52]
1.47 [0.94, 2.31]
0.55 [0.16, 1.89]
0.83 [0.42, 1.64]
0.49 [0.27, 0.89]
0.87 [0.69, 1.10]
1.18 [0.80, 1.74]
1.00 [0.57, 1.75]
2.23 [0.97, 5.13]
0.90 [0.35, 2.31]
0.90 [0.75, 1.08]
1.35 [0.93, 1.96]
1.15 [0.78, 1.70]
0.98 [0.88, 1.10]
Year
2003
2003
2004
2005
2005
2007
2007
2008
2008
2008
2008
2008
2009
Risk Ratio Risk Ratio
IV, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 6 Impact of multiple micronutrients supplementation in pregnancy on stillbirths.
Imdad et al. BMC Public Health 2011, 11(Suppl 3):S4
http://www.biomedcentral.com/1471-2458/11/S3/S4
Page 9 of 13
significant statistical heterogeneity in the pooled esti-
mate (I2=20%) (Figure 5). The overall grade quality evi-
dence for the pooled estimate was that of ‘low’ level due
to inadequate method of sequence generation and allo-
cation concealment of the two of the included studies.
The total numbers of stillbirhs in all the three included
studies was less than 50. According to CHERG rules, it
is a pre-requisite for an estimate to be considered for
inclusion in the LiST model that the total number of
events is at least greater than 50 [16]. It should also be
noted that all three included studies used different for-
mulas to deliver the intervention. There is no single
proven formula to recommend on large scale. Thus the
value of protein supplementation is uncertain.
There was no effect of multiple micronutrient supple-
ments on incidence of stillbirths compared to iron-folate
supplementation alone. The Cochrane review on the
subject by us in 2006 [7], however, did not have any
meta-analysis on stillbirths as outcome. Most of the stu-
dies in the current analysis were representative of low-
or middle-income populations. As the results were not
statistically significant, we do not recommend MMN
supplementation during pregnancy for inclusion in the
LiST for reduction of stillbirths. A recently published
review on MMN showed similar results [84].
In conclusion, folic acid fortification reduces incidence
of neural tube defects and may also have an effect on
stillbirths. This estimate of 41% reduction has been
recommended as a proxy for reduction in stillbirths due
to NTDs, for inclusion in the LiST model. Based on 3
studies balanced protein energy supplementation during
pregnancy may reduce all-cause stillbirths by 45%.
While promising, there is need of more operations
research before we can recommend this intervention on
large scale for reducing stillbirths. There is no evidence
of effect of multiple micronutrients supplementation on
reducing stillbirths.
Additional material
Additional File 1: The search strategies used for the above
mentioned nutritional interventions on PubMed.
Additional File 2: Data extraction sheet for studies included in the
review.
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Table 3 Quality assessment of studies of multiple micronutrients supplementation during pregnancy to prevent
stillbirths
Quality Assessment Directness Summary of
findings
No. of
studies
(Ref)
Design Limitations Consistency Generalizability
to Population
of Interest
Generalizability to intervention of
Interest
Relative Risk
(95 % CI)
Stillbirth: Low outcome specific quality
13 RCT Methods of sequence
generation and allocation
concealment were not
explicitly described in few of
the studies
Heterogeneity in
the pooled data
was not
significant
(I2=38%)
All included
studies from
developing
countries
Nine studies used UNIMMAP formulation
(30 mg iron, 400 µg folic acid, 15 mg
zinc, 2 mg copper, 65 µg selenium, 800
µg RE vitamin A, 1.4 mg vitamin B1, 1.4
mg vitamin B2, 18 mg niacin, 1.9 mg
vitamin B6, 2.6 µg vitamin B12, 70 mg
vitamin C, 5 µg vitamin D, 10 mg
vitamin E and 150 µg iodine)
0.98 (0.88-1.10)a
Peri-natal mortality: Low outcome specific quality
11 RCT Methods of sequence
generation and allocation
concealment were not
explicitly described in few of
the studies
Significant
heterogeneity
(I2=56%).
Random models
used
All included
studies from
developing
countries
Nine studies used UNIMMAP formulation
(30 mg iron, 400 µg folic acid, 15 mg
zinc, 2 mg copper, 65 µg selenium, 800
µg RE vitamin A, 1.4 mg vitamin B1, 1.4
mg vitamin B2, 18 mg niacin, 1.9 mg
vitamin B6, 2.6 µg vitamin B12, 70 mg
vitamin C, 5 µg vitamin D, 10 mg
vitamin E and 150 µg iodine)
1.07 (0.92 –
1.25)a
a: generic inverse variance.
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